← Leaderboards
Lakshmi Pendyala
Roswell Park Cancer Institute Corp
$2,646,119
Attributed
$2,646,119
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $419.8K · FY2005–12$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
'12
Funding mix
By agency
NIH$2,646,119 · 3
By mechanism
R01$1,509,047 · 1
R21$637,367 · 1
P30$499,705 · 1
Top collaborators
No co-investigators on record.
Most similar at Roswell Park Cancer Institute Corp
Same institution · by research overlap
- Carl W Porter$5,047,582
- Dominic James Smiraglia$3,001,000
- Clement C Ip$9,662,404
- Hayley Affronti$278,317
- Aryn Rowsam$62,560
Others in their field
Top investigators on “Platinum”
- Philip J Disaia · University Of California Irvine$96,259,393
- Charles A Coltman · Southwest Oncology Group$55,360,646
- Gregory H Reaman · National Childhood Cancer Foundation$17,052,970
- Marco Pahor · Wake Forest University Health Sciences$14,682,885
- Stephen J Lippard · Boston University Medical Campus$13,445,194
- Shadi Dayeh · University Of California, San Diego$11,494,972
Research focus
PlatinumGene ExpressionPolyaminesMalignant NeoplasmsBaseMolecularPharmaceutical PreparationsAnalogFutureChemopreventive AgentAnthracyclinesEnzyme ActivityAntimetabolitesBiologicalDoctor Of PhilosophyFluorescenceComputer SoftwareCancer Center Support GrantData AnalysesDetectorDrug Delivery SystemsDrug KineticsConsultationsClinical Protocols
Grant awards (12)
Pharmacokinetics$104,240
P30 · FY2012 · CA · contact PI
Pharmacokinetics$112,636
P30 · FY2011 · CA · contact PI
Pharmacokinetics$123,088
P30 · FY2010 · CA · contact PI
Polyamine Catabolism in Platinum Drug Action$301,591
R01 · FY2009 · CA · contact PI
Pharmacokinetics$118,210
P30 · FY2009 · CA · contact PI
Polyamine Catabolism in Platinum Drug Action$297,716
R01 · FY2008 · CA · contact PI
Pharmacokinetics$41,531
P30 · FY2008 · CA · contact PI
Polyamine Catabolism in Platinum Drug Action$293,954
R01 · FY2007 · CA · contact PI
Polyamine Catabolism in Platinum Drug Action$305,395
R01 · FY2006 · CA · contact PI
Polyamine Catabolism in Platinum Drug Action$310,391
R01 · FY2005 · CA
Molecular Correlates--Oxaliplatin/5FU/XRT, Esophageal CA$320,733
R21 · FY2002 · CA
Molecular Correlates--Oxaliplatin/5FU/XRT, Esophageal CA$316,634
R21 · FY2001 · CA